Setting new pathways for the innovation in spinal surgery for the benefits of patients and healthcare systems in the EU

About

Novel Bone Regeneration Drug Osteogrow: Therapeutic Solution for Lumbar Back Pain

The overall vision of OSTEOproSPINE is to provide a long-term solution for the treatment of degenerative spine disorder through a personalised bone implant.

Utilising the research results of the former H2020 project OSTEOGROW, OSTEOproSPINE will be setting new pathways for the innovation in spinal surgery for the benefits of millions of patients worldwide.

Learn more

Photo of Prof. Slobodan Vukicevic, OSTEOproSPINE coordinator

In OSTEOproSPINE we will use the patient’s peripheral blood and translate it to extra skeletal bone, based on the research results of our previous project OSTEOGROW.

By combining the protein with allograft we will ensure a quicker bone generation and avoid a second surgical procedure for the patients to harvest bone from the pelvis.

Prof. Slobodan Vukicevic, OSTEOproSPINE coordinator
University of Zagreb School of Medicine

Latest News

Facts and Figures

Background

Millions of people worldwide suffer from chronic lumbar back pain, which is the second most common medical condition after a cold. Because of its chronic nature, lumbar back pain constitutes an enormous burden for patients and leads to very high costs for healthcare systems.

Mostly caused by degenerative spine disorders, approximately 1.5 million patients in the EU alone need a surgical intervention to treat lumbar back pain.

Learn more

Consortium

University of Zagreb School of Medicine logo
Genera Research d.o.o. logo
University of Vienna School of Medicine logo
Department of Neurosurgery, Kepler University Hospital, Linz logo
Medical University of Graz logo
EURICE – European Research and Project Office GmbH logo
Clinres farmacija d.o.o. logo
Smart Medico d.o.o. logo
Triadelta partners Ltd logo
2KMM logo
University of Zagreb Faculty of Veterinary Medicine logo